Alkermes plc

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Alkermes plc - overview

Location

-, California, US

Primary Industry

Pharmaceuticals

About

Based in Ireland, Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases.


Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceuticals

Verticals

HealthTech

Total Amount Raised

Subscriber access only

Alkermes plc - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Alkermes plc - financials

Fiscal Year EndedMar 31, 2012Dec 31, 2013Dec 31, 2014Dec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue (USD)152,100,000242,600,000447,100,000481,400,000539,600,000611,600,000718,800,000722,900,000685,000,000881,800,000697,500,000---
% Revenue Growth (YoY)---7.7%12.1%13.3%17.5%0.6%(5.2%)28.7%(20.9%)---
EBITDA (USD)19,800,00014,400,0007,300,000(149,900,000)(41,800,000)(14,700,000)20,800,00022,200,00038,800,000186,200,000(37,100,000)---
Operating Income (USD)(9,800,000)(35,300,000)(65,800,000)(231,900,000)(144,000,000)(120,000,000)(89,700,000)(65,700,000)(51,400,000)97,300,000(129,500,000)---
Operating Margin(6.4%)(14.6%)(14.7%)(48.2%)(26.7%)(19.6%)(12.5%)(9.1%)(7.5%)11.0%(18.6%)---
% EBITDA Margin13.0%5.9%1.6%(31.1%)(7.7%)(2.4%)2.9%3.1%5.7%21.1%(5.3%)---
NET Income (USD)(13,400,000)(54,600,000)(78,800,000)(254,000,000)(181,300,000)(165,600,000)(157,900,000)(155,800,000)(123,100,000)9,700,000(201,500,000)---
% Net Margin(8.8%)(22.5%)(17.6%)(52.8%)(33.6%)(27.1%)(22.0%)(21.6%)(18.0%)1.1%(28.9%)---

Alkermes plc - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Corporate Carve OutCompletedAlkermes plc's Development and Manufacturing Facility in Athlone-
Trade SaleCompletedRodin Therapeutics Inc.-
Trade SaleCompletedCivitas Therapeutics Inc.-
Series CCompletedCivitas Therapeutics Inc.-
Series BCompletedCivitas Therapeutics Inc.-

Displaying 1 - 5 of 7

Alkermes plc - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.